• Research
    • Our Mission
    • Multidrug Therapies
    • Surveillance
    • Stewardship
    • Education & Outreach
    • Publications
  • Resources & Services
    • Drug Combinations Lab
    • Levy CIMAR Summer Internship
    • AMR Pre-College Program
    • Educational Resources
    • For Levy CIMAR Faculty
    • Our Values
  • Publications
  • People
    • Leadership
    • Core Faculty
    • Affiliate Members
    • Featured Trainees
    • About Stuart B. Levy, M.D. 
  • News
    • Upcoming Events
    • Levy CIMAR in the News
    • Press Releases
  • Giving
  • Contact

Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial.

by Levy CIMAR | Sep 1, 2018 | Publications

The piglet acute diarrhea model for evaluating efficacy of treatment and control of cryptosporidiosis

by Levy CIMAR | Aug 27, 2018 | Publications

Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin.

by Levy CIMAR | Aug 1, 2018 | Publications

Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin.

by Levy CIMAR | Aug 1, 2018 | Publications

Stereospecific Synthesis of the Saccharosamine-Rhamnose-Fucose Fragment Present in Saccharomicin B

by Levy CIMAR | Jul 17, 2018 | Publications

Page 80 of 86« First«...102030...7879808182...»Last »

Recent Posts

  • EXPRESS: Factors associated with antimicrobial drug prescription in cats receiving outpatient care at a veterinary teaching hospital
  • Loss of essential outer membrane functions causes drug hypersensitization in Acinetobacter baumannii overexpressing multidrug efflux pumps
  • Growth arrest of Mycobacterium tuberculosis in acidic environments enhances their survival of antibiotic treatment
  • Point-Counterpoint: The “obsoletogram”—are annual hospital antibiograms still relevant?
  • Species-level reporting of Coagulase-negative staphylococci with MALDI-TOF does not impact clinical outcomes

The Levy CIMAR is a collaboration of Tufts Medical Center and the Tufts University Office of the Vice Provost for Research (OVPR) Research and Scholarship Strategic Plan (RSSP).

Contact us



South Cove 502, 136 Harrison Ave. Boston, MA. 02111



(617) 636-3824



CIMAR@tufts.edu

Join the CIMAR mailing list

Stay updated with our latest research, events and news.

© 2026 LevyCIMAR. All Rights Reserved.